Cholecystokinin-antagonist lorglumide inhibits osteogenic differentiation in human bone marrow stem cells

This publication has 31 references indexed in Scilit:

• Gastrointestinal cholecystokinin signaling pathway drugs modulate osteogenic/cementogenic differentiation of human periodontal ligament stem cells
  Journal of Dentistry, 2025
• Alkaline Phosphatase Activity of Serum Affects Osteogenic Differentiation Cultures
  ACS Omega, 2022
• A quantitative method to determine osteogenic differentiation aptness of scaffold
  Journal of Oral Biology and Craniofacial Research, 2020
• c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines
  Purinergic Signalling, 2016
• Tissue non-specific alkaline phosphatase production by human dental pulp stromal cells is enhanced by high density cell culture
  Cell and tissue research, 2015
• Expression pattern differences between osteoarthritic chondrocytes and mesenchymal stem cells during chondrogenic differentiation
  Osteoarthritis and Cartilage, 2010
• Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway
  Current Therapeutic Research, 2010
• Undifferentiated human mesenchymal stem cells (hMSCs) are highly sensitive to mechanical strain: transcriptionally controlled early osteo-chondrogenic response in vitro
  Osteoarthritis and Cartilage, 2007
• Regulation of the initiation of pancreatic digestive enzyme protein synthesis by cholecystokinin in rat pancreas in vivo
  Gastroenterology, 2000
• Release of cholecystokinin in the central nervous system
  Neurochemistry International, 1993